GoodRx responds to CVS Health's new pharmacy reimbursement model, highlights existing acquisition-cost pricing

GoodRx Holdings, Inc.

GoodRx already hosts discount card pricing agreements informed by acquisition cost-based pricing at CVS Pharmacy and other key retailers.
Company plans to continue implementing acquisition cost-based approach with retail partners pursuing this model.
Sees its hybrid pharmacy contracting strategy as well positioned for evolving reimbursement models.
Disclosure follows CVS Health's recent announcement of a new pharmacy reimbursement formula based on drug cost plus markup and fee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.